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Agriculture Under Threat — A Crisis Of
Confidence? The Solution: Redefine
Adventitious Presence Maximum Levels from
Zero to Zero++
Mark Perry and Ramesh Karky*
The issue of Adventitious Presence (AP) of genes, those that are not “natu-
rally” present in food and crops but rather have been placed there using recombi-
nant deoxyribonucleic acid (DNA) technology, has become a hot issue for produc-
ers and consumers. It can also be a major problem for exporters. Part of this
problem is the reality that zero presence is now impossible to guarantee in some
crops and products. Pressure has arisen to establish a Low Level Presence (LLP)
threshold, one that is above zero, to be determined at an international level. This
would allow crops to be imported and exported without the AP genes being ap-
proved in the importing country if they are approved in another country. The real-
ity of biotechnological innovation in crops is that it is inevitable that there will be
gene “flow” between varieties. This article examines the background of AP, the
current state of policy and legislation, and why this has become contentious for
producers, importers and exporters. This article examines the Canadian position
towards AP as an illustration of a nation that produces many agricultural products
based on genetically modified crops.
INTRODUCTION
Conventional and organic agriculture is said to be struggling for survival.1
Under the laws of many countries, conventional and organically grown crops are
not protected from the effects that genetically modified organisms (GMOs)2 may
have on their marketability. Due to the lacuna in regulation, the effects and con-
cerns caused by genetically modified crops are being addressed outside any specific
* Mark Perry is a Professor of Science and of Law at the University of Western Ontario;
currently he is on leave to the University of New England, Australia, where he is
pursuing his research in Biotechnology and Intellectual Property Laws. Ramesh Karky
is a Postdoctoral Fellow at the University of Western Ontario.
1 For a description of the situation regarding Canadian non-genetically modified farm-
ing, see Chidi Oguamanam, “Tension on the Farm Fields: The Death of Traditional
Agriculture?” (2007) 27 Bulletin of Science, Technology & Society 260
[Oguamanam].
2 Despite being mis-descriptive, “genetically modified organisms” has become the term
that is generally accepted for organisms that have been created using recombinant
DNA and generated by molecular cloning. Such plants transformed through this type of
genetic engineering are under discussion herein.
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regulatory framework.3 Furthermore, the stakeholders such as biotechnology com-
panies, conventional and organic farmers, and the public at large, are being ex-
cluded from policy making processes.4 Since the Triffid flax issue, where non-ap-
proved GM in flax was exported from Canada and reached 35 countries,5 the
Canadian Government has lurched into action in pursuing international standards,
at least for adventitious presence (AP)6 that can be classified as a “Low Level Pres-
ence” (LLP).7 The alteration of conventional8 or organic9 crops by transfer of
genes from genetically modified (GM) crops through cross-pollination is now not
uncommon.10 Indeed, one argument being made at the international level today is
that due to the wide adoption of GM crops in many exporting countries, it is be-
coming impossible to maintain a zero tolerance policy without serious trade
disruption.
The CDC Triffid Flax case in Canada provides a good example of how GM
can linger even after it was thought to have been removed from the ecosystem. The
Triffid was developed by the Crop Development Centre of the University of Sas-
katchewan to give it tolerance to soil residues of the herbicides triasulfuron and
metsulfuron-methyl, used to control broadleaf weeds in wheat crops, as otherwise
3 Jane Matthews Glenn, “The Coexistence of Genetically Modified and Non-genetically
Modified Agriculture in Canada: A Courtroom Drama” in Luc Bodiguel & Michael
Cardwell, eds, The Regulation of Genetically Modified Organisms: Comparative Ap-
proaches (New York: Oxford University Press, 2010) 254 at 255 [Glenn].
4 Ibid. at 255-56.
5 Mr. Alex Atamanenko during the Second Reading and Referral to Committee on 14
April 2010 of Bill C-474 “An Act respecting the Seeds Regulations (analysis of poten-
tial harm)” which was defeated at report stage (9 February 2011).
6 Herein the term adventitious presence (AP) is used to refer to both genes that have
entered conventional and organic crops, as well as mixture of GMO product with con-
ventional/organic product, for example crop being mixed in the grain conveyor.
7 Although the term is being used a lot in the current discussions on “low levels” of AP,
there are arguments as to what it means.
8 The issue of the makeup of conventional crops is discussed in Mark Perry, “What’s so
conventional about conventional crops: non-recombinant DNA techniques for geneti-
cally modified organisms” (Conventional, working title, forthcoming).
9 Organic production in Canada has a GM exclusion as detailed in the National Stan-
dards of Canada, “Organic Production Systems General Principles and Management
Standards” CAN/CGSB-32.310-2006 as amended in June 2011 at s.1.4.1: “it is forbid-
den to use any of the following substances or techniques:
All materials and products produced from genetic engineering as these are not compati-
ble with the general principles of organic production and therefore are not accepted
under this standard . . .”
10 Over 15 years ago, in AM Timmons, YM Charters, JW Crawford, D Burn, et al, “Risks
from transgenic crops” (1996) 380 Nature 487, it was predicted that in a region where
only 10% of the fields were sown as transgenic, genetic “contamination” would reach
0.1% at a distance of over 2km.
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flax could not be typically grown on the same land for around two years.11 Trials
were started in 1988, and unconfined release, and its use as livestock feed, were
sanctioned in May 1996.12 However, the CDC Triffid was deregistered in 2001 due
to indirect pressure from the European Union (which did not want to import the
variety as it is a GMO) and farmers (70% of EU flax seed product imports came
from Canada). At the time there were around 200,000 bushels of the seed being
prepared for making commercial seed stock. This was crushed at a central location
to remove the Triffid from the market. Clearly something in the removal process
was at fault as in September 2009 genes from the Triffid variety were found in
Germany, triggering the EU rapid response protocols. Canada responded by testing
flax before export to avoid loss of crop after export. The cost over two years has
been estimated at around $29 million.13
As this shows, even very low levels14 of AP can affect the price and market
access for conventional and organic crops, causing economic loss to growers and
dealers of such crops. AP has raised multiple issues relating to the coexistence of
GM crops and other crops, liability, and some claim even the protection of health
(both human and animal),15 protection of the environment,16 and market access.17
There are some issues that are concomitant with GMO use and AP:
11 Canadian Food Inspection Agency, “DD1998-24: Determination of the Safety of the
Crop Development Centre’s ‘CDC Triffid’, a Flax (Linum usitatissimum L.) Variety
Tolerant to Soil Residues of Triasulfuron and Metsulfuron-methyl” 1996-05.
12 Ibid.
13 Dr Camille Ryan, “Revisiting the Triffid Issue” presentation at Saskatoon Flax Day
conference (9 January 2012).
14 With a zero tolerance policy, 0.01% is set as the threshold; this number is determined
by the current testing sensitivity and reliability. This equates in a single test in corn to
around one seed in 10,000, or one kernel in around 3.8kg of corn.
15 Ikechi Mgbeoji, “Adventitious Presence of Patented Genetically Modified Organisms
on Private Premises: Is Intent Necessary for Actions in Infringement Against the Pro-
perty Owner?” (2007) 27:4 Bulletin of Science, Technology and Society 314; G Licht-
man, “The Economics of Innovation: Protecting Unpatentable Goods” (1997) 81 Min-
nesota L Rev 693; T Demeke, DJ Perry & WR Scowcroft, “Adventitious presence of
GMOs: Scientific overview for Canadian grains” (2006) 86:1 Canadian Journal of
Plant Science 1; M Phillipson, “Are genetically modified crops in Canada under-regu-
lated?” (2008) 18:2 J Envtl L & Prac 195.
16 Martin TK Tsui & LM Chu, “Aquatic toxicity of glyphosate-based formulation: com-
parison between different organisms and the effects of environmental factors” (2003)
52:7 Chemosphere 1189; CP Rogers, “Liability for the Release of GMOs into the Envi-
ronment: Exploring the Boundaries of Nuisance” (2003) 62:2 Cambridge Law Journal
371; J Glenn, “Genetically Modified Crops in Canada: Rights and Wrongs” (2003) 12 J
Envtl L & Prac 281.
17 Drew L Kershen & Alan McHughen, “Adventitious Presence: Inadvertent Commin-
gling and Coexistence among Farming Methods” (July 2005) QTA2005-1 The Council
for Agricultural Science and Technology (CAST) Commentary [Kershen]. CG Gonza-
lez, “Trade liberalization, food security, and the environment: The neoliberal threat to
sustainable rural development” (2004) 14:2 Transnational Law & Contemporary
Problems 419; Richard A Repp, “Biotech Pollution: Assessing Liability for Genetically
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• Should conventional or organic crops (or plants) that are found to have
AP be considered to be “Plants with Novel Traits (PNTs) and regulated
as such;
• Will a country allow the importation of conventional or organic products
into the market with AP (non-approved) without risk assessment?
• What is the international market-access situation for agricultural products
that have AP?
• Is there any mechanism that allows for coexistence of GM, conventional
and organic crops, but minimizes the level of AP?
• Will there be compensation, and by whom, for farmers of conventional or
organic crops who suffer loss due to AP?
• Is agricultural regulation primarily the responsibility of parliament or re-
gional governments?
• How is AP dealt with under patent laws?18
• What is a “Low Level Presence” that can be considered insignificant?
• Is society now forced to accept GM presence?
Many of these questions remain unanswered in many nations, and have not been
addressed directly by policy or regulation. This article examines the Canadian posi-
tion as an illustration of a GM producing nation that is moving towards recalibrat-
ing the meaning of risk assessment, organic plants, AP in non-GM plants, and cov-
ers the issues of coexistence, liability and trade disruption.
I. CODEX ALIMENTARIUS CONSIDERATIONS
The Codex Alimentarius Commission is a joint commission of the World
Health Organisation and the Food and Agricultural Organisation, both United Na-
tions Specialised Agencies.19 It has been tasked with establishing health and safety
standards and regulating international food trade, and is a powerful influence on
international food regulation developments. Although the Canadian Triffid issue
came as a surprise for flax exporters and the Canadian Government alike, the Sixth
Session of the Codex Alimentarius Ad Hoc Intergovernmental Task Force on
Modified Crop Production and Genetic Drift” (2000) 36:3 Idaho L Rev 585 at 593
[Repp]; Norman C Ellstrand, Honor C Prentice & James F Hancock, “Gene Flow and
Introgression from Domesticated Plants into their Wild Relatives” (1999) 30 Ann Rev
Ecology & Systematics 539 at 541 [Ellstrand]. See also David S Bullock, Marion
Desquilbet & Elisavet Nitsi, “The Economics of Non-GMO Segregation and Identity
Preservation” (2002) 27:1 Food Policy 81 at 83 [Bullock]; Katie Black & James Wi-
shart, “Containing the GMO Genie: Cattle Trespass and the Rights and Responsibilities
of Biotechnology Owners” (2008) 46 Osgoode Hall LJ 397 at paras. 10 and 11 [Black
& Wishart].
18 Mgbeoji, supra note 15.
19 The Commission has a long history of over a century. It was formally established as
part of the joint World Health Organisation and Food and Agricultural Organisation in
1963. See Sami Shubber, “The Codex Alimentarius Commission under International
Law” (1972) 21:4 The International and Comparative Law Quarterly 631.
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Foods Derived from Biotechnology set up a working group on LLP, chaired by the
United States of America (USA) and co-chaired by Germany and Thailand, in
2006. The Task Force put a proposed draft forward, and had it considered at the
Seventh Session at the Task Force’s September 2007 meeting in Chiba, Japan.20
Although the Task Force on LLP did not address the meaning or measure of
LLP, it provided an annex to the Codex Alimentarius Commissions’ Plant Guide-
lines addressing LLP and discussed two “dietary exposure” situations. The first be-
ing from commodities, which tend to be mixed and “diluted,” such as grain, beans
and oils, and second from foods consumed whole, such as fruits and vegetables.
The former is the more likely scenario.21
The Task Force proposal allows jurisdictions to adopt a short food safety as-
sessment for imported product with LLP, should they wish to so do. The key ad-
vance made by the Task Force was the recommendation for there to be a database
available on recombinant DNA plants that have been authorized under Codex
guidelines,22 to allow for the Annex to be applied. In addition to details on the
authorizing country and type, the important requirement is that information on
where protocols for detection can be obtained. This allows an importing country, of
canola for example, to request testing data to see if imports contain recombinant
DNA approved in the exporting country, or growing country.23
The Codex Alimentarius Commission accepted the Annex on LLP and it is
now part of the Guideline for the conduct of Food Safety Assessment of Foods
Derived from Recombinant-DNA Plants.24 There are some limitations on the ab-
breviated assessment that may be adopted; for example, if a country has already
rejected authorization of a recombinant-DNA instance it would not be likely that it
would approve any AP, even LLP.
The key issue yet to be adopted at an international level is the meaning of LLP
in terms of thresholds; that is the maximum AP that can be considered LLP, the
number of tests required, and how testing is conducted. The current status of evalu-
ation continues to lead to uncertainty for trading crops. Most countries to date have
had a zero tolerance policy. In addition to Triffid and other Canadian product inci-
dents, problems have also arisen inside the European Union. For example, in
20 Codex Alimentarius CX/FBT 07/7/1, Agenda Item 1 May 2007 for the Joint
FAO/WHO Food Standards Program, Codex Ad Hoc Intergovernmental Task Force on
Foods Derived from Biotechnology Seventh Session Chiba, Japan, 24–28 September
2007. The United States had made a similar proposal to form an ad hoc Task Force on
LLP at the Fifth Session in 2005, but it was not accepted at that time.
21 Report of The Seventh Session of The Codex Ad Hoc Intergovernmental Task Force on
Foods Derived From Biotechnology Chiba, Japan, 24–28 September 2007, ALINORM
08/31/34, Appendix IV at para. 4.
22 Section 3 of the Guideline for the Conduct of Food Safety Assessment of Foods De-
rived from Recombinant-DNA Plants — CAC/GL 45-2003.
23 This is under European Union Commission Regulation No 619/2011, 24 June 2011.
24 Codex Alimentarius Commission Thirty-first Session International Conference Centre,
Geneva (Switzerland), 30 June–4 July 2008, Report al31REPe, adopting Annex on
Food Safety Assessment in Situations of Low-level Presence of Recombinant-DNA
Plant Material in Food (N07-2007) ALINORM 08/31/34 Appendix IV.
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Bablock,25 a German honey producer found that his honey contained MON810
Maize pollen (likely from a nearby field where the test MON810 crop had been
grown). The European Court of Justice decided that as MON810 was not approved
for consumption in the EU, the honey and pollen could not be sold.26
II. PLANTS WITH NOVEL TRAITS
Canada is the fifth largest producer of GM crops in the world.27 Canada’s
regulatory approach is to assess all plants that show “novel traits” whether these are
achieved by recombinant-DNA technologies or otherwise. The most prominent of
Canada’s GM crops are canola, corn and soybeans which are all increasing in size
of plantings. With the exception of Prince Edward Island,28 which has considered
banning the cultivation of GM crops, there is little market acceptance problem for
GM crops in Canada. In general, the subject matter of biotechnology has been man-
aged in Canada through regulations for Plants with Novel Traits (PNTs). There is
no specific “biotechnology law” or “recombinant-DNA food regulation” in Canada.
The Federal Regulatory Framework for Biotechnology (1993), which is the govern-
mental policy addressing biotechnology, recommends using existing legislation and
regulatory institutions to deal with biotechnology — the Canadian policy approach
was, and still is, unique in that it examines “product” not “process.”29 The Cana-
dian Environmental Protection Act, 1999 (CEPA) requires that all products of bio-
technology new to Canada be subject to an assessment of their potential “toxicity”
before they can be manufactured, imported or sold in Canada. In 2004, the Stan-
dards Council of Canada adopted (as a standard) the Standard for Voluntary Label-
ling and Advertising of Foods that Are and Are Not Products of Genetic
Engineering.30
25 EC, Court of Justice Decision 2011/EC Karl Heinz Bablok and Others v. Freistaat
Bayern, [2011] OJ C 442/09 [Bablok]. In addition to the honey, pollen and Triffid Flax
cases, there have been many other occurrences of crops and foods being removed from
markets due to AP.
26 Ibid.
27 Clive James, “Global Status of Commercialized Biotech/GM Crops: 2009” ISAAA
Brief No 41. ISAAA: Ithaca, NY.
28 Irené Novaczek & Laura Fanning, “The Economic, Social and Environmental Implica-
tions of Genetically Modified Crops (GMOs) on Islands” (2012) UPEI Institute of Is-
land Studies, online: <http://www.upei.ca/iis/rep_gmo_1>.
29 The Canadian approach is to regulate “Plants with Novel Traits,” however created.
This is the responsibility of the Canadian Food Inspection Agency (CFIA) under Plant
Protection Act (SC 1990, c 22), Seeds Act (RSC, 1985, c. S-8) and their regulatory
structure. The CFIA was established by the Canadian Food Inspection Agency Act (SC
1997, c. 6).
30 Mark Cantley, “An Overview of Regulatory Tools and Frameworks for Modern Bio-
technology: A Focus on Agro-Food” (Paper prepared for the OECD International Fu-
tures Project on “The Bioeconomy to 2030: Designing a Policy Agenda,” February
2007), online: Organisation for Economic Co-operation and Development
<http://www.oecd.org/dataoecd/11/15/40926623.pdf> at 67 [Cantley].
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Canada is a signatory of the Cartagena Protocol31 but has yet to ratify the
Protocol. The United States Department of Agriculture has stressed the interdepen-
dence of Canada/US trade, making the point:32
Canada relies heavily on United States of America exports of major grains
and oilseeds like corn and soybeans to meet the needs of its processing and
livestock industries. The ratification of the Protocol by Canada could have
an impact on future imports of genetically modified grains from the United
States.
Canada, the USA and Mexico have been working together on the development
of biotechnology regulatory policy through the North American Biotechnology Ini-
tiative for over a decade. Indeed, Canada and the USA have an unprecedented bilat-
eral agreement on agricultural biotechnology.33 They forged their agreement in
1998 with the intent to “compare and harmonize” the regulatory process and pre-
market assessments of GM plants between the two countries.34 In addition to har-
monization of assessment, another aim is to discuss “future areas of cooperation
and information exchange that will facilitate the safe incorporation of transgenic
plants into agricultural production and commerce.”35 Prior to this agreement, both
countries were already performing case-by-case assessments of proposed GM
plants before they were released.36
The Canadian regulatory approach to GM plants is unique. Unlike the use of
the term “genetically modified” (GM) in the European Union and other countries,
Canada prefers to use the term “genetically engineered” (GE), which is a more
narrow definition.37 Canada regulates plants on the basis of the traits expressed and
not on the basis of the method used to introduce the traits. Plants with novel traits
(PNTs) are defined as a plant containing a new trait not present in plants of the
same species in Canada. Such new traits are intentionally selected, created or intro-
duced into the population of that species using recombinant-DNA techniques,
mutagenesis, cell fusion or even conventional cross breeding methods, typically to
31 Cartagena Protocol on Biosafety to the Convention on Biological Diversity, 29 January
2000, UN Doc 2000 (entered into force on 11 September 2003).
32 United States, United States Department of Agriculture, USDA Foreign Agricultural
Service GAIN Report CA6036: Canada, Biotechnology, Agricultural Biotechnology
Report 2006 (2006) at 3 [GAIN].
33 Canada and United States, Canada and United States Bilateral on Agricultural Bio-
technology, 16 July 1998, online: United States Department of Agriculture Animal and





37 In a literal sense, all living things are “genetically modified”for example creating a
hybrid corn by “traditional” methods. See Mark Perry, “From Pasteur to Monsanto:
Approached to Patenting Life in Canada in Ysolde Gendreau”, An Emerging Intellec-
tual Property Paradigm — Perspectives from Canada (Edward Elgar 2008), online:
<http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1291344>.
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introduce pest or herbicide resistance, but more recently crops with “stacked” traits
are being approved.38
Hence, in Canada, “Plants with Novel Traits” covers broader types of plants
than the term “genetically modified plants” does in Europe or other countries: 
For products like wheat and canola developed through mutagenesis, which
by the definition of biotechnology in Canada fall under the PNT heading
and require regulatory approval, do not require regulatory approval in the
United States.39
Since PNTs have the potential to affect health (human, plant and animal) and
the environment, all PNTs are subject to safety assessments before they can be
produced, cultivated or commercialized.40 The objective here is to protect
human/animal health and the environment. Assessments include: an environmental
review for field trials (confined research field trials), a second environmental re-
view prior to commercialization (unconfined release of PNTs), a livestock feed
safety review, a food safety review, and variety registration (for most field crops).41
The Seeds Act42 and the Seeds Regulations Part V,43 regulate confined re-
search field trials and unconfined release of PNTs. The Plant Protection Act44 and
the Plant Protection Regulations45 regulate the importation of PNTs. Directive
2000-07, Directive for the Environmental Release of Plants with Novel Traits
Within Confined Research Field Trials in Canada, provides guidance for the sub-
mission of an application for the authorization of a confined research field trial.
Directive 94-08, Assessment Criteria for Determining Environmental Safety of
Plants with Novel Traits, provides guidance for the submission of an application for
the authorization of an unconfined release of a PNT. Furthermore, “Scientists
working with GMOs, including the development of PNTs, adhere to Canadian In-
stitute for Health Research directives, as well as the codes of practice of their own
institutional biosafety committees. These guidelines protect the health and safety of
laboratory staff and ensure environmental containment.”46
38 For example SmartStax corn where eight known traits have been inserted into the
plant’s genome in order to give it resistance against root and surface pests, as well as
herbicide tolerance. See Mark Perry, “Genetically modified organisms: why we need a
transparent system of regulation” Lawyers Weekly (4 September 2009) online:
<http://ssrn.com/abstract=1533657>.
39 GAIN, supra note 32 at 5.
40 The CFIA: “A PNT is a plant that contains a trait which is both new to the Canadian
environment and has the potential to affect the specific use and safety of the plant with
respect to the environment and human health,” online: <http://www.inspection.gc.ca>.
41 The CFIA provides a description of the process. Online:
<http://www.inspection.gc.ca/plants/plants-with-novel-traits/general-public/eng/
1337380923340/1337384231869> [CFIA].
42 Seeds Act, RSC 1985, c. S-8.
43 Seeds Regulations, CRC, c. 1400.
44 Plant Protection Act, SC 1990, c. 22.
45 Plant Protection Regulations, SOR/95-212.
46 Cantley, supra note 30 at 66.
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The Plant Biosafety Office (PBO) of the Canadian Food Inspection Agency
(CFIA) is responsible for regulating the environmental release of PNTs. The PBO
works closely with the Biotechnology Environmental Release Assessment unit
(BERA), which is responsible for environmental safety assessments of PNTs.
Overall, the CFIA is responsible for regulating the importation, environmental re-
lease, variety registration, and the use in livestock feeds of PNTs. This authority
has been given to the CFIA by the Plant Protection Act,47 Plant Protection Regula-
tions,48 Seeds Act49 and Seeds Regulations (Part V).50 CFIA responsibilities in-
clude approval of unconfined release of PNTs, approval and inspection of confined
research field trials of PNTs, assessment of import applications for PNTs, develop-
ment of domestic regulatory policies related to the environmental release of PNTs,
and development of internationally aligned regulatory policies through participa-
tion in various international forums.51 If the PNT has insecticidal expression, the
CFIA also works with Health Canada’s Pest Management Regulatory Agency
(PMRA) in the regulatory reviews. Health Canada is responsible for assessing the
(human) health safety of foods, including novel foods, and approving their use in
the market.52 Environment Canada is responsible for administering the New Sub-
stances Notification Regulations53 and for performing environmental risk assess-
ments of toxic substances under the Canadian Environmental Protection Act
(CEPA), including organisms and micro-organisms that may have been derived
through biotechnology.54
III. FIELD TRIALS OF PNTS
In Canada, notification and authorization is needed for the commercialization
of PNTs. Consequently, an environmental risk assessment is required for research
using confined field trials that are evaluated by government scientists to determine
that the trials will not harm the environment. Following this, a more detailed envi-
ronmental assessment is required for unconfined release into the environment. If
the plant or crop is to be used as livestock feed, it must be assessed for safety
before it can be used for commercial production. It must also undergo a separate
food safety assessment process by Health Canada in cases of human consumption.
There are several purposes behind such confined research field trials:
47 Supra note 44.
48 Supra note 45.
49 Supra note 42.
50 Supra note 43.
51 CFIA, supra note 41.
52 Food and Drugs Act (RSC, 1985, c. F-27).
53 These regulations are made under Canadian Environmental Protection Act, 1999 (SC
1999, c 33).
54 See Canadian Environmental Protection Act, 1999 (SC 1999, c 33), Seeds Act, RSC
1985, c. S-8, Seeds Regulations, CRC, c. 1400, Plant Protection Act, SC 1990, c. 22,
Plant Protection Regulations, SOR/95-212, and the flowchart “Flow Chart — Regula-
tion of Plants with Novel Traits in Canada”, online:
<http://www.inspection.gc.ca/plants/plants-with-novel-traits/general-public/eng/
1337380923340/1337384231869>.
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• to give scientists opportunities to study the environmental safety of the
plants;
• to give developers an opportunity to evaluate the performance of the
plants in the natural environment (instead of a laboratory or greenhouse);
• to provide information that the CFIA requires to complete environmental
assessments, livestock feed assessments, and food safety assessments if a
developer later submits an application for unconfined release; and
• to generate data that can be used for variety registration.55
During an environmental safety assessment, the potential risks of each plant
with novel traits are identified on a case-by-case basis, based on science. The pro-
cess is designed to limit the impact of novel plants on the environment. The CFIA
evaluators examine the plant’s molecular characteristics. The evaluators determine
the new or modified genes in the plant, how they are likely to behave, and if the
new plants are likely to cause harm to the environment (noted below). Available
peer-reviewed scientific literature and expert advice from the scientific community
are also used in the assessment process. If the applicant wants to use material from
the field trial in a research feeding study, the PBO of the CFIA will forward the
field trial application to the Agency’s livestock feed evaluators. The PBO also pro-
vides information to the Pest Management Regulatory Agency on issues involving
testing novel herbicide tolerance or insect resistance. The PBO also sends non-con-
fidential information to designated provincial governments where trials will take
place. Furthermore, the CFIA sends non-confidential information on authorized
field trials to the Organization of Economic Co-operation and Development Bio-
Track database. After the completion of the confined research field trial, evaluators
inform the applicant of their decision. A summary of the assessment is made avail-
able to the public, and the plants with novel traits, their seeds, and other plant mate-
rial harvested from the confined trial will be destroyed.56
IV. UNCONFINED ENVIRONMENTAL RELEASE OF PNTS
A PNT cannot be authorized for unconfined release without determining its
risks to health and the environment. Developers need to submit an application for
the unconfined environmental release of a PNT to the PBO. An application for
unconfined environmental release of a PNT must address the environmental safety
requirements provided by Directive 94-08, Assessment Criteria for Determining
Environmental Safety of Plants with Novel Traits. In this respect, Directive 2009-
09: Plants with novel traits regulated under Part V of the Seeds Regulations:
Guidelines for determining when to notify the CFIA, also provides criteria and in-
formation requirements for the environmental safety assessment of PNTs. A PNT is
considered safe to be released into the environment if it does not pose potential
55 See CFIA “Confined Research Field Trials for Plants With Novel Traits (PNTs)”, on-
line: <http://www.inspection.gc.ca/plants/plants-with-novel-traits/general-public/fact-
sheets/field-trials/eng/1338138305622/1338138377239>.
56 Canada, Canadian Food Inspection Agency Plant Products Directorate, Directive 94-
08: Assessment Criteria for Determining Environmental Safety of Plants with Novel
Traits (Ottawa: Plant Biosafety Office, 2000), and discussed by CFIA.
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safety concerns (human, animal, or environmental) compared to traditionally de-
veloped counterparts used in Canada.
Before these plants are released into the environment, government evaluators
assess potential impacts on the environment. Environmental safety assessments of
PNTs examine the following possible impacts:
• the potential of the plant to become a weed or to be invasive of natural
habitats;
• the potential for gene flow to wild relatives;
• the potential for a plant to become a plant pest;
• the potential impact of a plant or its gene products on non-target species;
and
• the potential impact on biodiversity.57
Of these five areas of potential impact, some may require further analysis. For
example, the potential for insects to develop resistance to a pesticide as a result of
releasing certain modified plants into the environment. In such a situation, the ap-
plicant may be asked by the CFIA to submit an insect resistance management plan
for farmers to put in place. Also, some potential risks can be managed by imposing
conditions such as limiting the geographical location for cultivation.
The above-mentioned risk assessment process has been heavily criticised: 
The CFIA relies heavily on data and information provided by the biotech-
nology companies themselves in making its scientific assessment; this data
is evaluated by CFIA scientists but not made available for peer-reviewing.
The CFIA also relies on the biotechnology companies for post-release moni-
toring. The public is almost totally excluded from the pre- and post-release
processes, and the information made available to it is sketchy.58
Variety registration is critical for a seed certification system. In Canada, only
authorized PNTs are registered, and the crops that are subject to variety registration
are listed under Schedule III of the Seeds Regulation. The CFIA Variety Registra-
tion Office (VRO) is responsible for registering varieties of PNT crops in Canada.
In this area the VRO works closely with the PBO. 
Canada’s system of registration for newly developed crop varieties ensures
that only varieties with proven benefits to producers and consumers are
sold. Once approved for use in field trials, varieties are evaluated in regional
field trials by whom . . . this is contradicting the above criticism. Plant vari-
eties produced through biotechnology cannot be registered and sold in Can-
ada until authorized for environmental, livestock feed and food safety. For
products containing stacked genes, there is a notification system, which may
lead to the requirement of an environmental safety assessment.59
Once environmental, feed and food safety authorizations are granted, the
PNT and feed and food products derived from it can enter the marketplace,
but are still subject to the same regulatory scrutiny that applies to all con-
ventional products. Any new information arising about the safety of a PNT
57 Ibid. at s. 6.1.
58 Glenn, supra note 3 at 267.
59 Cantley, supra note 30 at 67.
36   CANADIAN JOURNAL OF LAW AND TECHNOLOGY [11 C.J.L.T.]
or its food products must be reported to government regulators who, upon
further investigation, may amend or revoke authorization and/or immedi-
ately remove the product(s) from the marketplace.60
In Canada, at least to date, authorization has not been granted for commercial
cultivation for Plant Molecular Farming (PMF); nor is there any commercial PMF,
although there have been a number of trials.61 It is expected that developers will
soon seek approval for commercial production of PNTs for molecular farming. Re-
garding labelling and traceability, there are no specific regulatory requirements for
PNTs or for novel foods in Canada. Consumer groups argue that the labelling re-
quirement for PNTs and novel foods supports both a right to choice and a right to
be informed. The Canadian government rejected a Bill requiring labelling or disclo-
sure of genetically modified content in February 2011.62 Similarly, in the United
States, although the Genetically Engineered Food Right-to-Know Act63 was tabled
in Congress in 1999, it was never enacted. The FAO/WHO Codex Alimentarius
Commission (Codex) has also shown interest in labelling GMO products; Codex
discussions have recently come to a consensus after two decades.64
The Canadian system regulating PNTs is not without criticism, and it has been
argued that the Canadian concept brings non-GMO plants within the subject matter
of environmental risk assessment and varieties registration, which are not regulated
in most other countries (such as European countries and the United States of
America). “The concept of PNTs as developed and applied in Canada is time con-
suming, expensive and an innovation barrier for Canadian plant breeding. It is a
threat to the constructive use of plant mutations for crop improvement . . .”65 How-
ever, the regulation of only organisms that have been altered by recombinant DNA
techniques seems to be a narrow approach that misses the purpose of food safety —
namely to prevent harmful crops being used in agriculture.66
V. CANADIAN LEGISLATIVE FRAMEWORK: ORGANIC
PLANTS
Canadian farmers have been growing conventional and organic crops, plants
and foods for a long time. While PNTs are costly and time consuming to create
60 Ibid.
61 For example, using interleukin derived from tobacco plants to treat Crohn’s disease.
62 James Bradshaw, “Ottawa rejects stronger export regulations for genetically modified
crops”, The Globe and Mail (16 February 2011) online: The Globe and Mail
<www.theglobeandmail.com>.
63 United States, Genetically Engineered Food Right-to-Know Act, 106th Congress: 2nd
Session, Section 2080 (2000).
64 The Codex Alimentarius Commission, “Compilation of Codex texts relevant to label-
ling of food derived from modern biotechnology” (2011) CAC/GL 76-2011 online:
<http://www.codexalimentarius.org/standards/list-of-standards/en/>.
65 GG Rowland, “The Effect of Plants with Novel Traits (PNT) Regulation on Mutation
Breeding in Canada” in QY Shu, ed, Induced Plant Mutations in the Genomics Era
(Rome: Food and Agriculture Organization of the United Nations, 2009) 423 at 424.
66 The issue of the safety of plants developed by mutagenesis is outside the scope of this
article, but one that an author is considering in Conventional, supra note 8.
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(and mainly it is only large companies that can afford such development), organic
farming is affordable to ordinary farmers and is a source of sustainability, con-
tinuity and job creation. As in the United States of America, the European Union,
Japan, and many other countries, organic crops and food are regulated in Canada.
The law requires that organic producers obtain certification in order to market food
as organic. Anybody who wants to claim their product as organic must comply with
the Canadian laws regarding organic crops. The Organic Products Regulations
2009,67 created under section 32 of the Canada Agricultural Products Act,68 apply
to food and feed, including agricultural crops, and also apply to the cultivation of
plants.69 Adherence to the Canadian Organic Standards is mandatory for such prod-
ucts. The Regulations introduced a uniform approach to organic product certifica-
tion and labelling, and facilitate international market access. They provide specific
protection to consumers against deceptive and misleading labelling practices. Sec-
tion 1 of the Organic Products Regulations defines “organic product” as “an agri-
cultural product that has been certified as organic in accordance with these Regula-
tions or that has been certified as organic under section 27.”70
Under the Organic Products Regulations, the CFIA regulates organic agricul-
tural products in Canada, and the CFIA is responsible for compliance, verification,
and enforcement of the regulations, including label inspections in the marketplace
and audits of the Conformity Verification Bodies (CVBs). The Canadian Organic
Office of CFIA has also prepared an operating manual containing policies and pro-
cedures for activities applicable to the Canadian Organic Regime (COR). The Reg-
ulations set out the functions of the COR’s two oversight bodies: CVBs and Certifi-
cation Bodies (CBs). In this context, the CFIA enters into agreements with
Conformity Verification Bodies (CVBs). The CVBs are designated to assess, rec-
ommend for accreditation, and subsequently monitor CBs. The accredited CBs are
responsible for the organic certification of agricultural products and organic prod-
uct packaging and labelling certification.
The name of the certification body must be on the label. Organic products that
contain at least 95 percent organic content can be labeled as “Organic” and feature
the “Biologique Canada Organic” logo. This rule applies to both imported and do-
mestic products. However, if any organic product does not meet the required quali-
fication after the issuance of certification, such certification will be cancelled. If
somebody wants to place a Canadian Organic label on crops, products or plants, the
following substances or techniques, in either the production or handling stages, are
forbidden by the Canadian General Standards Board:
• All materials and products produced from genetic engineering;
• Synthetic pesticides, wood preservatives or other pesticides, except as
specified in CAN/CGSB-32.31;
• Fertilizer or composted plant and animal material that contains a prohib-
ited substance;
67 Organic Products Regulations, SOR/2009-176 [OP Regulations].
68 Canada Agricultural Products Act, RSC 1985, c. 20 (4th Supp).
69 OP Regulations, supra note 67 at s. 2.
70 Ibid.
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• Sewage sludge used as a soil amendment;
• Synthetic growth regulators;
• Synthetic allopathic veterinary drugs, including antibiotics and parasiti-
cides, except as specified in this standard;
• Synthetic processing substances, aids and ingredients, and food additives
and processing aids including sulphates, nitrates and nitrites, except as
specified in CAN/CGSB-32.311;
• Ionizing radiation and forms of irradiation on products destined for food;
and
• Equipment, packaging materials and storage containers or bins that con-
tain a synthetic fungicide, preservative or fumigant.71
Unlike in the European Union, there is no concept of GM-free crops, seeds or
products in Canadian legislation. There is a difference between the meaning of the
GM-free logo and the meaning of the organic logo. In Canada, the organic logo
does not mean it is purely organic or GM free. Such organic crops, plants or seeds
may contain genetically modified genes. If the AP of genetically modified plants or
seeds on such organic crops, plants or seeds is not more than five percent, the or-
ganic logo is allowed.72 In the European Union, if there is more than 0.9 percent of
the AP of genetically modified genes in a product then it is considered genetically
modified and will require labelling to that effect. Furthermore, it has to be an ap-
proved GM. There is no minimum threshold point for seeds. From the European
standard, many Canadian organic crops or products could potentially be considered
as GMOs.73
AP can affect price and market access for conventional and organic crops.
Where AP becomes part of non-GM harvests, farmers may find themselves in
breach of their contractual obligations and/or without markets for their goods.74
The scale of loss can be enormous. In 1999 and 2000, American farmers lost access
to almost the entire US$200 million European Union corn export market due to the
contamination of food corn stocks across the United States of America by the Star-
Link gene, a modification approved for feed corn only.75 Also, when StarLink
corn, which is also banned in Japan, was found to be mixed with non-GM corn
shipments from the United States of America, the result was “trade disruption and
considerable political turmoil.”76 The economic harm caused by GMO contamina-
tion was not only limited to farmers who grew organic or conventional analogues
71 Canada, Canadian General Standards Board, Organic Production Systems General
Principles and Management Standards (2006) online: Canadian General Standards
Board <http://www.tpsgc-pwgsc.gc.ca/ongc-cgsb/index-eng.html>.
72 Organic Products Regulations, 2009 SOR/2009-176 under the Canada Agricultural
Products Act (RSC, 1985, c. 20 (4th Supp)).
73 “Report From the Commission to the European Parliament and the Council on the ap-
plication of Council Regulation (EC) No 834/2007 on organic production and labelling
of organic products” Brussels, 11.5.2012 COM(2012) 212 final.
74 Black & Wishart, supra note 17 at para. 10.
75 Ibid. at para. 11; see also Repp, supra note 17 at 593.
76 Ibid. See also Ellstrand, supra note 17 at 541; Bullock, supra note 17 at 83.
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of GM crops. In 1999, European Union authorities discovered a small percentage
of transgenic pollen in Canadian honey shipments from Western Canada, much of
which was produced amongst GM canola fields. The authorities responded by ban-
ning Canadian honey from the European Union, seriously damaging a ten-million
dollar market.77
In response, the Government of Canada initiated negotiations of acceptance
for Canadian organic products with key trading partners. It entered into an agree-
ment for the trade of organic products with the United States of America in June
2009 and with the European Union on an organic equivalency arrangement in June
2011. However, the reality is different. Faced with the inevitable and near-perma-
nent AP in their fields with transgenic seeds, many organic and conventional farm-
ers have been left with no option but to sign the license agreements and sow the
crops offered by the biotech corporations.78
VI. CANADIAN LEGISLATIVE FRAMEWORK ON AP
While Canada is currently able to harness the benefits of GMOs, the issue of
AP of GM genes in non-GM crops/plants has not been addressed by policy or law.
AP, through pollen from GM crops for example, is unintended and unavoidable.
Similarly, for some crops such as canola, it is very difficult to ensure absolute sepa-
ration between GM and non-GM seeds when they share the same equipment at any
stage in their processing. AP is a complex issue that has direct implications on
regulations, marketing approaches, importing and exporting, and health and safety.
This issue must be addressed in order to build public confidence in a science-based
regulatory regime. There is neither a threshold of AP, nor even a definition, to
determine when the presence in products will cause them to be considered as genet-
ically modified crops or plants with novel traits or novel foods. At the third regular
meeting of the Food Regulatory Advisory Committee of Health Canada (Consulta-
tion on Canada’s Domestic Policy Review on Low-Level Presence of GMOs in
Imported Crops), on October 25-26, 2011, the Canadian Government recognized
that LLP has been an issue since the introduction of GMOs and is increasingly a
source of trade disruption internationally. In accordance with the executive sum-
mary of the meeting, the Government is assessing three options to manage LLP in
food products: 
Approach 1: Apply an action level for low-level presence for products im-
ported into Canada;
Approach 2: Apply an interim threshold for low-level presence for products
where a data package has been submitted to Canadian authorities; and
77 Ibid.
78 Ibid. See also Birgit Muller, “Infringing and trespassing plants: Patented seeds at dis-
pute in Canada’s courts” (2006) 48 Focaal European Journal of Anthropology 83
[Muller].
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Approach 3: Apply appropriate case-by-case thresholds for low-level pres-
ence in products imported into Canada.79
Canada is set to unveil to the world its proposal to permit
traces of unapproved genetically modified organisms in im-
ported foods, . . .. The federal government’s draft plan for
managing the low-level presence of GMOs in food and
feed products, to be submitted to the World Trade Organi-
zation in September, will undergo more consultations in
Canada.80
At last the Canadian administration is trying to address the issue, although this
just covers foods being imported into Canada, although it is a part of the interna-
tional WTO negotiations. However, this doesn’t provide any solutions for crop pro-
ducers in terms of regulation or liability for AP, nor does it meet face on the larger
policy stance on the regulation of PNTs in Canada.
Measures of minimizing AP levels and issues of compensating for the loss of
conventional or organic crop status due to the AP require policy direction. Cur-
rently, there are no laws or governmental policies to regulate this issue. There are
also no provisions to determine compensation for any economic losses that may
result from such contamination.
In Europe, when DNA of GM maize was found in honey, the European Court
of Justice (ECJ) decided that honey and food supplements containing pollen de-
rived from a GMO are considered foodstuffs produced from GMOs,81 and cannot
be marketed without prior authorization for the sale of the product from which the
pollen came.82 The ECJ set out that the Directive on genetically modified orga-
nisms (GMOs)83 provides that GMOs may be released deliberately into the envi-
ronment or placed on the market only when prior authorization has been given.84 It
stipulated the regulation on genetically modified food85 provided that GMOs for
food use, foodstuffs containing or consisting of GMOs, or foodstuffs produced
from ingredients produced using or containing GMOs must be authorized before
79 Consultation on Canada’s Domestic Policy Review on Low-Level Presence of GMOs
in Imported Crops, online: <http://www.hc-sc.gc.ca/fn-an/consult/frac-ccra/meeting-
reunion-2011-10-25-eng.php>, 16 August 2012.
80 Sarah Schmidt, “Canada ready to unveil plan to ease trade of genetically modified
foods,” The Gazette, 15 August 2012.
81 Bablok, supra note 25.
82 Ibid. at para. 109.
83 EC, Commission Directive 2001/18/EC of the European Parliament and of the Council
of 12 March 2001 on the deliberate release into the environment of genetically modi-
fied organisms and repealing Council Directive 90/220/EC, [2001] OJ, L 106 at 1, as
amended by EC, Commission Regulation No 1829/2003 and by Regulation (EC) No
1830/2003 of the European Parliament and of the Council of 22 September 2003,
[2003] OJ, L 268 at 24.
84 Muller, supra note 78 at para. 92.
85 EC, Commission Regulation (EC) No 1829/2003 of the European Parliament and of
the Council of 22 September 2003 on genetically modified food and feed, [2003] OJ, L
268 at 1.
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being placed on the market.86 In Canada, neither the judicial nor legislative
branches have addressed such issues. Are plants or crops or food with AP consid-
ered GMO crops or food and subject to a risk assessment procedure? There is no
answer. The absence of law and policy will create confusion and lack of confidence
among consumers, and will have multiple implications on Canadian agricultural
products in the domestic and international markets.
In May 2004, the Saskatchewan Court of Queen’s Bench, in Hoffman v.
Monsanto Canada Inc.,87 dismissed a certification application filed by a group of
organic farmers to initiate a class action against Monsanto and Bayer Cropscience
for revenue lost due to contamination of their organic canola crops. The plaintiffs
were certified organic farmers who wanted certification to sue for financial losses
suffered as a result of the introduction of Roundup Ready and Liberty Link Canola.
The dismissal of the class action suit simply means that the case cannot go
forward as a class action, but organic farmers could still sue on an indivi-
dual basis . . . The court’s reasoning in this regard suggests that farmers who
grow GM crops might find themselves as defendants in a lawsuit filed by
neighbors who complain about crop contamination.88
It has been noted that in Canada a patent holder has all the benefits of ownership
but none of the corresponding obligations.89
The Canadian regulatory framework takes what might be described as a
hard-edged, market-driven approach to third party economic loss occa-
sioned by GMOs. It has no specific provisions about coexistence, nor does it
address the problems of economic and other fallout when cross-pollination
or commingling occurs.90
Seed purity and identity are also linked to AP, and can also cause trade disrup-
tion.91 As an exporter, Canada cannot ignore the influence of the demands made by
its customer countries. Customers’ perception of Canada’s inability to limit AP
may result in the loss of Canadian export markets.
86 Muller, supra note 78 at para. 109.
87 (2005), 264 Sask. R. 1 (Q.B.); affirmed 2007 SKCA 47; leave to appeal refused 2007
CarswellSask 725 (S.C.C.) [Hoffman].
88 Jodie L Hierlmeier, “Under the microscope: litigation, law reform, and genetically
modified crops” (2005) 30:2 L Now 32.
89 J de Beer, “The Rights and Responsibilities of Biotech Patent Owners” (2007) 40:1
UBCL Rev 343.
90 Glenn, supra note 3 at 256.
91 As could be seen with the Triffid flax issue, supra note 11 et seq. The Canadian Seed
Trade Association: “the international trade of seed is threatened by the lack of interna-
tional standards surrounding the adventitious presence of non-approved genetic events
in seed” online: <http://cdnseed.org/archive/pdfs/press/Position%20on%20
Adventitious%20Presence.pdf>.
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VII. IS AP A PATENT ISSUE?
The Canadian Patent Act92 defines “innovation” as “any new and useful art,
process, machine, manufacture or composition of matter, or any new and useful
improvement in any art, process, machine, manufacture or composition of mat-
ter.”93 Since the early 1980s, the Canada Patent Office has allowed the patenting of
genes. In 2002, the Supreme Court of Canada, in its decision in Harvard College v.
Canada (Commissioner of Patents),94 ruled that genes were patentable subject mat-
ter, but higher life forms were not patentable. Canada’s approach of patenting
genes is similar to the United States of America and European systems. The Euro-
pean Patent Convention (EPC) defines patentable subject matter as, “. . . any inven-
tions which are susceptible of industrial application, which are new and which in-
volve an inventive step,”95 and allows gene patenting. In the United States of
America, section 101 of the Patent Act defines patentable inventions as, “whoever
invents or discovers any new and useful process, machine, manufacture, or compo-
sition of matter, or any new and useful improvement thereof, may obtain a patent
therefore, subject to the conditions and requirements of this title.” Section 101 of
the Patent Act permits the patentability of “compositions of matter.”96 The United
States of America Supreme Court in Diamond v. Chakrabarty97 held that “all com-
positions of two or more substances and . . . all composite articles, whether they be
the results of chemical union, or of mechanical mixture, or whether they be gases,
fluids, powders or solids” are patentable.98
In general, a patented gene will be protected by patent law, but such protection
has limitations. One of the requirements of patentability is usefulness. When GM
plants or crops start to be an AP in non-GM counterparts, a different issue arises.
“Concerns about adventitious presence are economic concern: market access, con-
tract specifications, and consumer preferences. The worry is that the mere presence
of the transgenic materials decreases the value of the conventional or organic crop,
especially in export market.”99
In Monsanto Canada Inc. v. Schmeiser,100 the plaintiff held a patent for a
species of canola resistant to glyphosphate-based herbicides, specifically Mon-
santo’s Roundup Ready canola. The defendant, Schmeiser, was a canola farmer
who had discovered that Roundup Ready canola had spread to his property from his
neighbors. He isolated this crop by using Roundup and stored the seed. The next
season he planted the Roundup Ready canola seed. Monsanto sued for patent in-
fringement and Schmeiser alleged that: 1) the patent was not valid as it dealt with a
higher life form; and 2) he was not infringing the patent as he did not use Roundup
92 RSC 1985, c. P-4.
93 Ibid. at s. 2.
94 2002 SCC 76, [2002] 4 S.C.R. 45 [Harvard College].
95 European Patent Convention, 1973, c. 1 s. 52(1).
96 35 USC s. 101 (1952).
97 447 U.S. 303 (U.S. Sup. Ct., 1980).
98 Ibid. at paras. 303 and 308.
99 Kershen, supra note 17 at 1.
100 2004 SCC 34, [2004] 1 S.C.R. 902 [Schmeiser].
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on the crop and thus was not making use of the patented trait. In this case in May
2004, the Supreme Court of Canada held the patent was valid because the claims
pertained to the gene and cells contained within the higher life form and not the life
form itself.101 The majority also held that the possession of a plant composed of
cells containing the patented gene constituted “use” and consequently Schmeiser
had infringed the patent by growing the canola without a license from Mon-
santo.102 In this case, the dissenting opinion focused on a narrower interpretation of
the scope of the patent protection, “. . . the patent’s ‘essential elements’ restrict the
scope of its protection to the gene and cell in isolation and does not extend protec-
tion over the plant and its offspring.”103 The minority opinion felt that, “the plants
containing the patented gene can have no stand-by value or utility as my colleagues
allege. To conclude otherwise would, in effect, confer patent protection on the
plant.”104
However, in Schmeiser, the court made it clear that they were not referring to
the accidental growing of the plant by adventitious spreading, but rather the delib-
erate cultivation (95% of Schmeiser’s crops were Round-up Ready).105 The Su-
preme Court noted it was up to Parliament to address the issue of treating geneti-
cally modified plants differently from other patented subject matter.106 The
Saskatchewan Court of Queen’s Bench, in Hoffman, stated: 
After the decision in Schmeiser, the Canadian Biotechnology Advisory
Committee recommended that the Patent Act be amended . . . to protect in-
nocent farmers from claims of patent infringement from the accidental or
spontaneous spreading (by wind or cross-pollination) of GM products. The
Committee also suggested the need to address liability and damages caused
by products of biotechnology, whether or not they have been patented. Can-
ada’s regulatory system currently does not address issues of liability or
damages with respect to the release of GM crops or other GM organisms
into the environment.107
Although Germany gives a similar kind of patent protection to patented genes
as Canada, Germany has also passed the Genetic Engineering Act,108 which guar-
antees the freedom of choice between transgenic, conventional and organic crops.
If GMO contamination is found on neighboring conventional or organic crops, the
law requires the GM farmer compensate any loss to conventional or organic farm-
ers. The law also requires the GM cultivator to maintain certain measures, such as
isolation distance from other crops. The Supreme Court of Germany has upheld the
101 Ibid. at paras. 17–24.
102 Ibid. at para. 58.
103 Nathan Fan, “Case Comment: Importing Cefetra’s Soy Meal Case into Canada: How
Well will Patents for Genetically Modified Plant Genes and Cells Found in a Residual
State Fare under Canada’s Patent Laws?” (2010) 22:3 IPJ 333 at 341.
104 Kershen, supra note 17 at para. 160.
105 Kershen, ibid. at para. 2.
106 Kershen, ibid. at para. 95.
107 Hoffman, supra note 87.
108 Gentechnikgesetz, BGB1 1990, 1 G 2121-60-1, 1080, as amended by BGB1 2010, 1 G,
1934.
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constitutionality of the Genetic Engineering Act.109 In 2005, the German Federal
State of Saxony-Anhalt had brought an action against the Genetic Engineering Act
before the Federal Constitutional Court of Germany. On 25 November 2010, the
Federal Constitutional Court of Germany dismissed the action and upheld the re-
strictive provisions for the cultivation of GM plants and liability. This law is also
known as the Coexistence Law. Sixteen European countries including France,110
Belgium,111 the Netherlands,112 and others, have a similar “coexistence law,” guar-
anteeing freedom of choice and provisions of compensation to non-GM farmers in
case of AP of GM crops. These types of laws provide opportunities for the coexis-
tence between transgenic, conventional and organic farmers, and a requirement of
standards for GM farmers to ensure a minimal impact of AP. These European
countries have also provided patent protection to genes and remedies in case of
infringement. This example clearly demonstrates that the issue raised by the AP of
GMOs on conventional or organic crops is different than the issue of gene patent
protection.
In Canada, 80% of the 6 million acres of canola grown are planted in GM
canola. The propensity for genes to spread, in other words AP, is at the heart of the
problem of coexistence between transgenic, organic and conventional crops. The
Canadian courts in both Schmeiser and Hoffman did not find it necessary to address
the root of the problem, but rather took a traditional perspective which can be seen
as strengthening the position of biotechnology companies: they can enforce their
patents but not have liability for their use.113 In some sense, the horse is pretty
much through the open barn door, and the concern is that if the AP issue is not
addressed immediately, the organic and conventional (traditional) farming industry
will simply be unable to continue.114 In Canada, preliminary policy exploration of
AP has underrated the seriousness of the phenomenon.115 It does not recognize the
109 German Federal Constitutional Court, Press Release, 108/2010, “Leitsätze : zum Urteil
des Ersten Senats vom 24. November 2010” (24 November 2010) online: Das
Bundesverfassungsgericht<http://www.bundesverfassungsgericht.de/entscheidungen/
fs20101124_1bvf000205.html>.
110 “Prévention des pollutions et des risques” Loin 2008-595 du 25 juin 2008 relative aux
organismes génétiquement modifiés, JO, 26 June 2008. See also Code de
l’Environnement art L531-1ff.
111 Arrêté royal du 21 février 2005 réglementant la dissémination volontaire dans
l’environnement ainsi que la mise sur le marché d’organismes génétiquement modifiés
ou de produits en contenant, 24 February 2005, (2005) Belgian Official Journal
7129–7165. See also Luc Lavrysen, “Belgian Report”, (Ghent: Ghent University 2006).
112 Coexistence Decree, 2005.
113 Glenn, supra note 3 at 254 and 257.
114 M Lee & R Burrell, “Liability for the Escape of GM Seeds: Pursuing the ‘Victim’?”
(2002) 65 Mod L Rev 517 at 518.
115 M Fulton, H Furtan, D Gosnell, R Gray, J Hobbs, J Holzman, B Kerr, J McNaughton, J
Stevens & D Stovin (eds.), “Transforming Agriculture: The Benefits and Costs of Ge-
netically Modified Crops,” Prepared for the Canadian Biotechnology Advisory Com-
mittee, Project Steering Committee on the Regulation of Genetically Modified Foods,
March 2001, 98–104.
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threats posed by GMOs for traditional agriculture and conventionally-bred cops.116
A loss of GM-free status caused by AP is a reality even though the demand for
organic foods has been rising and organic farming is a steadily growing industry in
industrialized countries.117
VIII. CONCLUSION
AP of GM genes in non-GM crops is now a reality. In short this means that
any foodstuff that contains product that somewhere in the world is produced
through GM technologies will have AP genes in them, if not now, then in the fu-
ture. The effect is that even those consumers in countries that do not allow the
production of GM crops will likely end up consuming GM products; if LLP is
adopted globally, they are unlikely to be aware of this new reality. One perspective
of AP genes is that they not only infiltrate and commingle with conventional and
organic crops, but they reduce, at least from the perspective of some of those that
are growing them, the “purity” of conventional and organic crops. Consequently,
conventional and organic crops face problems of market access and economic
losses. Adoption of LLP will change the meaning of “GM-Free” to become short-
hand for “GM-Free (apart from some small amount that your government thinks is
of such little effect that you can ignore it)”. There may also be additional negative
aspects of AP of GM genes, such as herbicide resistant weeds, which is outside the
discussion here, but is one that will become more important in the next decade.118
There are serious questions regarding the survival of coexistence between GM
crops, conventional crops and organic crops in Canada. How can we address the
problems brought by the AP of GM genes? There are neither statues nor regulations
in Canada that directly address this issue.
One approach would be to attempt to salvage some market space for non-AP
in conventional and organic crops:
• The issue of coexistence between crop types should be recognized as a
unique problem brought by agricultural biotechnology.
• A maximum AP level for conventional or organic crops (perhaps with
regard to export markets) should be adopted;
• There should be mandatory provisions for identification of PNTs and
novel foods in the Canadian market;
• Standards for “negative labeling,” for both organic plants and seeds
should be broadly adopted;
• There should be evaluation of PNTs to allow for coexistence between
genetically modified, conventional and organic crops, and minimize the
level of AP;
116 Oguamanam, supra note 1 at 269.
117 Ibid. at 268.
118 For example, twenty-three glycine resistant weed species have been identified to date.
Online: <http://www.weedscience.org/Summary/UspeciesMOA.asp?lstMOAID=12>,
and the ongoing survey HeapIM, “International survey of herbicide resistant weeds”
Weed Science Society of America (2012). Online: <http://www.weedscience.org/
In.asp>.
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• The question of economic loss for farmers of conventional or organic
crops who suffer due to AP must be addressed; and
• Jurisdictional issues between federal and provincial governments in re-
spect of PNTs and coexistence should be settled, as well as the new roles
of the PBO and CFIA.
To give effect to these recommendations, the Plant Protection Act of 1990 and
Plant Protection Regulations, Seeds Act of 1985 and Seed Regulations (Part V),
section 32 of the Canadian Agricultural Products Act of 1985 and Organic Prod-
ucts Regulations of 2009, Directive 2000-07, Directive 94-08 and Directive 2009-
09 would need to be amended at the same time.
The truth is that as a “global society” we now have no choice but to accept AP
in our food and feedstuff. In relation to some small trials, such as the Triffid flax, it
may be possible to “flush the system” of undesirable genes: 
It is not physically possible to eliminate GM flax from the existing breeder
seed lots. Consequently, the CDC has developed and applied a protocol to
reconstitute a number of flax varieties and re-release them as “Triffid-free”
Breeder Seed. This new breeder seed source is one of our best opportunities
to ensure the Canadian flax crop is free of Triffid seed. It is the intent of the
Canadian flax industry to flush the system of existing CDC seed stocks by
the fall of 2013 so that the portion of the commercial flax crop sown using
the reconstituted CDC flax varieties can be planted from this new seed
source as early as 2014.119
Whether this will happen remains to be seen, but even if this is a possible solution
for the Triffid flax AP this is not a viable solution for other GM crops that are still
in production. Technology may come to the rescue, with pollen free or male steril-
ity being engineered with the other traits. Public acceptance of these technological
solutions has not been great in the past, for example the so-called “terminator”
technologies.120
International bodies are mobilising as they see this as being an issue that needs
addressing soon. For example, the OECD’s Working Group on Harmonisation of
Regulatory Oversight in Biotechnology is working on the issue of LLP, and “con-
siders it a key issue in the context of environmental risk assessment.”121 However,
in the current situation, Canadian agricultural products carry both uncertainties and
confusion in both the international and domestic markets. Internationally, there are
considerable markets for conventional and organic crops/products, but the current
uncertainty brings no predictability of market acceptance, and is leading to a crisis,
leaving Canadian agricultural producers as the victims. AP is a relatively novel
legal issue created by biotechnology that has not been addressed by traditional lia-
bility or tort provisions in Canada. Because of its unique nature, it requires separate
legislation, as seen by the European precedent in the form of a Coexistence Law. It
119 Helen M Booker & Eric G Lamb “Quantification of Low-level GM Seed Presence in
Canadian Commercial Flax Stocks” AgBioForum, 15(1): 31–35. ©2012.
120 See e.g. Ehsan Masood “Monsanto set to back down over ‘terminator’ gene?” Nature
396, 503 (10 December 1998).
121 OECD “Biotechnology Update: Internal Co-ordination Group for Biotechnology news-
letter No 23 (8 March 2012).
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is a time to both analyze the Canadian stance on such issues, and adopt some form
of a Coexistence Law to clarify the legal coexistence between transgenic, conven-
tional and organic crops, to establish measures for minimizing adventitious pres-
ence, and to address the potential liability and damages due to the use of products
based on genetically modified crops.122
122 The issue continues to be highly contentious, the latest report in the Washington Post
Business 30th May 2013 “Japan suspends wheat imports from Pacific Northwest after
modified wheat discovered in Oregon,” online: <http://www.washingtonpost.com/busi
ness/usda-says-unapproved-genetically-engineered-wheat-discovered-in-oregon-field/
2013/05/30/2975da22-c902-11e2-9cd9-3b9a22a4000a_story.html>.
